It’s easy to spot motivated and engaged employees. They are more productive, they go the extra mile, and they display a sense of ownership in their work.But how do you replicate this culture throughout your organization? How do you encourage…
HOME > BUSINESS
BUSINESS
- Astellas Sales Up 1.1% Driven by Xtandi, OAB Drugs, despite Slump in Japan Business
November 1, 2018
- Sanofi, Daiichi Sankyo to Terminate Marketing Partnership for Hib Vaccine in Japan; Sanofi to Take Over Sales from Jan.
November 1, 2018
- Sumitomo Dainippon Operating Profit Plummets 50% on Drug Price Cut, Generic Erosions
October 31, 2018
- Mitsubishi Tanabe Sales Slip 1.7% as Radicava Boon Fails to Counter Japan Drop
October 31, 2018
- Mitsubishi Tanabe Paints Murky Outlook for US Sales Target on Parkinson’s Development Delay
October 31, 2018
- Nesp Biosame to Hit Japan Market in July-September 2019
October 31, 2018
- Otsuka Pharmaceutical Factory to Jointly Develop Regenerative Medicine Products with Startup
October 31, 2018
- Shionogi’s Half-Year Profits Renew Records, but Crestor Generics Weigh on Topline
October 30, 2018
- Shionogi Chief Confident about 70% Market Share for Xofluza in Japan
October 30, 2018
- Europe OKs Xtandi for All CRPC Cases
October 30, 2018
- JCR Initiates Development of Temcell for Epidermolysis Bullosa
October 30, 2018
- Takeda Mulls Sale of Shire GI Pipeline to Clinch European Clearance
October 29, 2018
- Fujifilm Signs MOU on Clinical Development of Favipiravir in China with 3 Chinese Partners
October 29, 2018
- Taiho’s Lonsurf Grabs US Priority Review Status for Gastric Cancer
October 29, 2018
- Daiichi Sankyo, Merck KGaA, Pfizer to Collaborate for PI of DS-8201, Bavencio, and DDR Combo
October 29, 2018
- Lemborexant Improves Nighttime Activity in AD Patients with Irregular Sleep-Wake Rhythm Disorder in PII: Eisai
October 29, 2018
- Eisai, Biogen Tout BAN2401’s Clinical Effect Regardless of APOE4 Mutation
October 29, 2018
- Shionogi, Osaka Univ. to Collaborate on Medical Data Science for Effective Use of Real-World Data
October 26, 2018
- Eisai to Offer 3 Rounds of Voluntary Retirement Program, to Cut 100 Jobs in March Next Year
October 26, 2018
- Xofluza Bags US Approval: Shionogi
October 26, 2018
ページ
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…